Daniel P Lew
Overview
Explore the profile of Daniel P Lew including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1679
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jousselin A, Kelley W, Barras C, Lew D, Renzoni A
Antimicrob Agents Chemother
. 2013 May;
57(7):3283-92.
PMID: 23629700
S. aureus combats cell wall antibiotic stress by altered gene expression mediated by various environmental signal sensors. In this study, we examined the transcriptional regulation of trfA, a gene related...
2.
Kelley W, Lew D, Renzoni A
J Infect Dis
. 2012 Aug;
206(8):1153-6.
PMID: 22904340
No abstract available.
3.
Jousselin A, Renzoni A, Andrey D, Monod A, Lew D, Kelley W
Antimicrob Agents Chemother
. 2012 Apr;
56(7):3629-40.
PMID: 22526301
Understanding in detail the factors which permit Staphylococcus aureus to counteract cell wall-active antibiotics is a prerequisite to elaborating effective strategies to prolong the usefulness of these drugs and define...
4.
Uckay I, Bernard L, Buzzi M, Harbarth S, Francois P, Huggler E, et al.
Antimicrob Agents Chemother
. 2011 Dec;
56(3):1258-64.
PMID: 22155824
Reduced susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates is considered a risk factor for failure of glycopeptide therapy. We compared the prevalences of MRSA isolates with reduced...
5.
Vaudaux P, Huggler E, Rhys-Williams W, Love W, Lew D
Int J Antimicrob Agents
. 2011 Mar;
37(6):576-9.
PMID: 21414759
Small-colony variants (SCVs) of Staphylococcus aureus are phenotypic variants characterised by their small colony size and improved intracellular survival and are associated with persistent and relapsing infections. XF drugs are...
6.
Didier J, Villet R, Huggler E, Lew D, Hooper D, Kelley W, et al.
Antimicrob Agents Chemother
. 2011 Mar;
55(5):1946-52.
PMID: 21357297
Intensive use of antimicrobial agents in health care settings not only leads to the selection of multiresistant nosocomial isolates of Staphylococcus aureus but may also promote endogenous, resistance-conferring mutations in...
7.
Andrey D, Renzoni A, Monod A, Lew D, Cheung A, Kelley W
J Bacteriol
. 2010 Sep;
192(22):6077-85.
PMID: 20870770
The Staphylococcus aureus SarA global regulator controls the expression of numerous virulence genes, often in conjunction with the agr quorum-sensing system and its effector RNA, RNAIII. In the present study,...
8.
Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew D
Antimicrob Agents Chemother
. 2010 Jun;
54(9):3861-70.
PMID: 20547791
Broth microdilution was compared with tube macrodilution and a simplified population analysis agar method for evaluating vancomycin and teicoplanin MICs and detecting glycopeptide-intermediate isolates of Staphylococcus aureus. Modal vancomycin and...
9.
10.
Renzoni A, Kelley W, Vaudaux P, Cheung A, Lew D
Trends Microbiol
. 2009 Dec;
18(2):55-6.
PMID: 20005114
No abstract available.